Benazepril Hydrochloride

規格

86541-74-4CAS番号

630-414-2EC番号

2-[(3S)-3-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid;hydrochlorideIUPAC名

C24H29ClN2O5化学式

460.9 g/mol分子量

BENAZEPRIL HYDROCHLORIDE; 86541-74-4; Benazepril HCl; Labopol; Tensanil; Zinadril; Cibace; DTXSID9045922; NSC-758920; CGS-14824A HCL; N1SN99T69T; CHEBI:3012; DTXCID7025922; CARDALIS COMPONENT BENAZEPRIL HYDROCHLORIDE; FORTEKOR PLUS COMPONENT BENAZEPRIL HYDROCHLORIDE; 1H-1-Benzazepine-1-acetic acid, 3-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-, monohydrochloride, (3S)-; 1H-1-Benzazepine-1-acetic acid, 3-(((1S)-1-(ethoxycarbonyl)-3-phenylpropyl)amino)-2,3,4,5-tetrahydro-2-oxo-, monohydrochloride, (3S)-; RefChem:54435; 680-262-6; CGS14824A; Lotensin; Cibacen; Cibacene; CGS 14824A HCl; MFCD00895734; 2-((S)-3-(((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)acetic acid hydrochloride; Benazepril (hydrochloride); C24H29ClN2O5; (3S)-3-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine-1-acetic acid hydrochloride; Cibacen CHF; (3S)-3-(((1S)-1-Carboxy-3-phenylpropyl)amino)-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine-1-acetic acid, 3-ethyl ester, monohydrochloride; 2-[(3S)-3-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid;hydrochloride; rel-(1S,3S)-Benazepril Hydrochloride; 1H-1-Benzazepine-1-acetic acid, 3-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-2,3,4,5-tetrahydro-2-oxo-, monohydrochloride, (S-(R*,R*))-; 2-[(3S)-3-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid hydrochloride; SMR000469199; CAS-86541-74-4; 88372-38-7; UNII-N1SN99T69T; Lotensi n; Cibacen;; NCGC00095132-01; Lotensin (TN); (3S)-3-[[(1S)-1-Carboxy-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine-1-acetic acid, 3-ethyl ester, monohydrochloride; 1H-1-Benzazepine-1-acetic acid, 3-[[1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-, monohydrochloride, [S-(R*,R*)]-; benazeprilhydrochloride; Benazepril hydrochloride [USAN:USP:JAN]; 86541-74-4 (HCl); benazepril monohydrochloride; Benazepril hydrochloride CRS; CHEMBL1694; SCHEMBL42194; MLS001076668; MLS001333171; MLS001333172; MLS001401429; SPECTRUM1505200; HY-B0093AR; orb1223813; orb1310864; SCHEMBL29381268; HY-B0093A; MSK10413A; HMS1922L07; Pharmakon1600-01505200; Benazepril HCl - Bio-X trade mark; TWT-8154; Benazepril hydrochloride (JAN/USP); Tox21_111441; BENAZEPRIL HYDROCHLORIDE [MI]; CCG-39520; EBC-11216; NSC758920; Benazepril for system suitability CRS; BENAZEPRIL HYDROCHLORIDE [JAN]; AKOS015888536; Benazepril (hydrochloride) (Standard); Tox21_111441_1; BENAZEPRIL HYDROCHLORIDE [HSDB]; BENAZEPRIL HYDROCHLORIDE [USAN]; CS-1796; FB59749; KS-1397; NC00211; NSC 758920; Benazepril hydrochloride [EP monograph]; BENAZEPRIL HYDROCHLORIDE [MART.]; BENAZEPRIL HYDROCHLORIDE [USP-RS]; BENAZEPRIL HYDROCHLORIDE [WHO-DD]; NCGC00165740-05; (3S)-3-[(1S)-1-Ethoxycarbonyl-3-phenylpropyl]amino-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine-1-acetic Acid Hydrochloride; 1H-1-Benzazepine-1-acetic acid, 2,3,4,5-tetrahydro-3-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-2-oxo-, monohydrochloride, (S-(R*,R*))-; 2-[(3S)-3-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid hydrochloride; BB164237; B3611; NS00134268; SW197591-3; BENAZEPRIL HYDROCHLORIDE [EP IMPURITY]; BENAZEPRIL HYDROCHLORIDE [ORANGE BOOK]; A12900; BENAZEPRIL HYDROCHLORIDE [USP IMPURITY]; BENAZEPRIL HYDROCHLORIDE [USP MONOGRAPH]; C07701; D00620; LOTREL COMPONENT BENAZEPRIL HYDROCHLORIDE; Benazepril hydrochloride, >=98% (HPLC), solid; EN300-6490178; BENAZEPRIL HYDROCHLORIDE COMPONENT CARDALIS; F862715; SR-01000762893; SR-01000762893-3; BENAZEPRIL HYDROCHLORIDE [EMA EPAR VETERINARY]; LOTENSIN HCT COMPONENT BENAZEPRIL HYDROCHLORIDE; Q27105927; Z2235801846; Benazepril hydrochloride, VETRANAL(TM), analytical standard; Benazepril Hydrochloride Working Standard (Secondary Reference Standard); Benazepril hydrochloride, European Pharmacopoeia (EP) Reference Standard; Benazepril for system suitability, European Pharmacopoeia (EP) Reference Standard; Benazepril hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material; Benazepril hydrochloride, United States Pharmacopeia (USP) Reference Standard; [(3S)-3-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid hydrochloride; [(3S)-3-{[(2S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl]amino}-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid--hydrogen chloride (1/1); 1H-1-Benzazepine-1-acetic acid, 3-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-, hydrochloride (1:1), (3S)-; 2-[(3S)-3-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid;hydrochloride; 866541-74-4別名